Glucometrics

GlucoMetrics was a medical technology company that specialized in the development of continuous glucose monitoring (CGM) solutions for the inpatient hospital setting. The company's core innovation was an intravascular, fluorescence-based sensor designed to provide real-time, accurate glucose readings for patients in intensive care units (ICUs). This technology aimed to replace intermittent manual testing, allowing for tighter glycemic control and the prevention of both hyperglycemia and hypoglycemia in critically ill patients. Although the company successfully advanced its sensor technology into clinical feasibility trials, it ultimately ceased operations before achieving full commercialization. GlucoMetrics was backed by prominent venture capital firms including Versant Ventures and Mohr Davidow Ventures.